<DOC>
	<DOCNO>NCT00418769</DOCNO>
	<brief_summary>Bioavailability study compare two new nilotinib tablet formulation establish nilotinib capsule formulation healthy volunteer</brief_summary>
	<brief_title>Bioavailability Study Comparing Two New Nilotinib Tablet Formulations Established Nilotinib Capsule Formulation Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Inclusion 1 . Healthy adult male ( 18 55 yr ) sterile post menopausal female subject 2 . Body weight must â‰¥50 kg &lt; 100 kg , body mass index ( BMI ) &gt; 18 &lt; 33 . 3 . Laboratory parameter value must fall within normal range Exclusion 1 . Female pregnant breast feeding . 2 . Contraindication receive nilotinib . 3 . Smokers user tobacco product 4 . A past medical history clinically significant Electrocardiogram abnormality , history/family history long QTinterval syndrome . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>nilotinib</keyword>
	<keyword>bioavailability</keyword>
	<keyword>tablet</keyword>
	<keyword>capsule</keyword>
	<keyword>PK</keyword>
	<keyword>healthy , subject ( ) ,</keyword>
</DOC>